Skip to main content

and
  1. No Access

    Article

    T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16

    Bispecific tetravalent antibodies (TandAb) directed against the B cell surface marker CD19 and activating receptors on T or NK cells (CD19 × CD3 or CD19 × CD16) have shown promising effects in vitro and in pre...

    Lisa M. Pörtner, Kathrin Schönberg, Maryam Hejazi in Cancer Immunology, Immunotherapy (2012)